Qube Research & Technologies Ltd

Position in SLDB — Solid Biosciences Inc.

CIK 1729829 LONDON, X0

Position in SLDB

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,367,660

+$1,218,552 QoQ

Shares Held

136,903

+267.3% QoQ

Ownership

0.128%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#54

of 155 holders

Holding Since

Mar 2021

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Qube Research & Technologies Ltd holds $2,443,042,063 across 169 Biotechnology names. SLDB ranks #113 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	798,715	$240,437,176
2	INSM	INSMED Inc	1,682,334	$179,370,451
3	REGN	Regeneron Pharmaceuticals, Inc.	221,607	$138,180,828
4	ROIV	Roivant Sciences Ltd.	3,454,496	$122,254,613
5	AXSM	Axsome Therapeutics, Inc.	426,336	$104,354,262
6	APGE	Apogee Therapeutics, Inc.	659,678	$87,559,060
7	TVTX	Travere Therapeutics, Inc.	1,443,230	$81,989,896
8	RPRX	Royalty Pharma plc	1,412,112	$79,177,119

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,367,660	136,903	+267.3%	Shares	Sole	2026-08-14
2024-12-31	$149,108	37,277	-50.0%	Shares	Sole	2025-02-14
2024-09-30	$519,397	74,519	-70.0%	Shares	Sole	2024-11-14
2024-06-30	$1,409,488	248,587	+90.3%	Shares	Sole	2024-08-14
2024-03-31	$1,740,231	130,648	+13064700.0%	Shares	Sole	2024-05-14
2023-12-31	$6	1	0.0%	Shares	Sole	2024-02-13
2023-09-30	$2	1	-100.0%	Shares	Sole	2023-11-13
2022-09-30	$26,371	56,471	-5.9%	Shares	Sole	2022-11-14
2022-06-30	$36,948	59,981	-39.5%	Shares	Sole	2022-08-15
2021-06-30	$362,709	99,101	+149.9%	Shares	Sole	2021-08-13
2021-03-31	$219,264	39,650	—	Shares	Sole	2021-05-14
No filing history on record for this holder in this stock.